← Back
$WGS All transactions

GeneDx Holdings Corp.

▼ SELL 10b5-1 Plan

$ Value

$491K

Shares

5,278

Price

$93

Filed

Jul 11

Insider

Name

Feeley Kevin

Title

CHIEF FINANCIAL OFFICER

CIK

0001944119

Roles

Officer

Transaction Details

Transaction Date

2025-07-09

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,392

Footnotes

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024. | Following the reported sales and option exercise, in addition to the 3,392 shares of Class A common stock and the option to purchase up to 6,228 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 135,762 shares of Class A common stock and additional options to purchase up to an aggregate of 20,924 shares of Class A common stock, which RSUs and options vest according to their respective terms. | 6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Filing Info

Accession No.

0001415889-25-019667

Form Type

4

Issuer CIK

0001818331

Feeley Kevin's History

Date Ticker Type Value
2026-03-26 WGS M $0
2026-03-26 WGS $152K
2026-03-26 WGS $60K
2026-03-26 WGS $159K
2026-03-26 WGS $64K
2026-03-26 WGS $121K
2026-03-26 WGS M $0
2026-01-29 WGS M $0
2026-01-29 WGS $30K
2026-01-29 WGS $184

Other Insiders at WGS (90d)

Insider Bought Sold Last
Stueland Katherine
CHIEF EXECUTIVE OFFICER
$3.1M 2026-03-26
Feeley Kevin
CHIEF FINANCIAL OFFICER
$587K 2026-03-26
Dechairo Bryan
Chief Operating Officer
$851K 2026-02-04